Evidence map›Paper›PMID 42534293›Full record

ArticleAdvances in neurotoxicology2026

Chemicals in cow milk and soy beverages: Neurotoxicity and neuroprotection.

Vanda Lopes de Andrade, Luisa M Mateus, Michael Aschner, Ana Paula Marreilha Dos Santos

Abstract read
In one paragraph

Article in Advances in neurotoxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Vanda Lopes de AndradeResearch Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisboa, Portugal.
Luisa M MateusResearch Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisboa, Portugal.
Michael AschnerDepartment of Molecular Pharmacology, Forchheimer Building, Room 209, Albert Einstein College of Medicine, Bronx, NY, United States.
Ana Paula Marreilha Dos SantosResearch Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisboa, Portugal.

Funding

Mechanisms of Manganese NeurotoxicityR01ES010563 · NIEHS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Michael Aschner, Aaron B Bowman · 2001 to 2026
$11.9M
NIEHS NIH HHS R01 ES010563
6 · The paper itself

Abstract

Cow milk constitutes a fundamental component of the human diet. Along with high nutritional value, contains neuroprotective components, caseins, lactoferrin, phospholipids and tryptophan. However, due to the use of pesticides in agriculture, veterinary drugs in livestock, and the presence of other contaminants, cow milk is frequently contaminated by these chemicals posing a risk to human health, namely through neurotoxicity. Strategies to decrease these contaminants include detoxification via microorganisms. Concomitantly, increased consumption of plant-based protein to substitute animal sources has been seen globally, being soy beverages (SB) utilized as an alternative to cow milk. Soy products are almost equivalent to animal sources in protein quality, and moreover, soy isoflavones like genistein, daidzein and glycitein and saponins, as well as soy peptides, may play neuroprotective roles. Conversely, neurotoxic risks associated with the consumption of soy beverages also exist, mainly due to the presence of excess of manganese, mycotoxins and consequences of human interventions during cultivation, resulting in pesticide residues, and pollution of soils, namely with metals. Due to the neurotoxicity and bioaccumulation of these contaminants, the fact that both cow milk and soy beverages are routinely ingested by all ages, and represent key ingredients in many processed foods, including baby foods, strict surveying of their levels is suggested.

Indexed as

Cow milkNeuroprotectionNeurotoxic contaminants.Soy beverage

Identifiers

PMID42534293
PMCPMC13420008

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.